Ubiquitination and dimerization of complement receptor type 2 on sheep B cells

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 458-466

  Hein, Wayne R ^a,b   Dudler, Lisbeth ^a   Marston, Wendy L ^a   Landsverk, Thor ^a,c   Young, Alan J ^a   Avila, David ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b AGRESEARCH   (New Zealand)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; UBIQUITIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; DIMERIZATION; IMMUNOPRECIPITATION; IMMUNOREGULATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SHEEP; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; BINDING SITES, ANTIBODY; BIOPOLYMERS; COMPLEMENT C3D; CYTOPLASM; DIMERIZATION; EXTRACELLULAR SPACE; HUMANS; ISOMERISM; LIGANDS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE MAPPING; POLYUBIQUITIN; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, COMPLEMENT 3D; SHEEP; UBIQUITINS;

EID: 0031858995     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Ahearn, J. M., and D. T. Fearon. 1989. Structure and function of the complement receptors. CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:183.
2. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127.
3. Melchers, F., A. Erdei, T. Schulz, and M. P. Dierich. 1985. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature 317:264.
4. Cahen-Kramer, Y., I-L. Martensson, and F. Melchers. 1994. The structure of an alternate form of complement C3 that displays costimulatory growth factor activity for B lymphocytes. J. Exp. Med. 180:2079.
5. Carter, R. H., M. O. Spycher, Y. C. Ng, R. Hoffman, and D. T. Fearon. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457.
6. Barel, M., A. Vazquez, C. Charriaut, M. T. Aufredou, P. Galanaud, and R. Frade. 1986. gp 140, the C3d/EBV receptor (CR2) is phosphorylated upon in vitro activation of human peripheral B lymphocytes. FEBS Lett. 197:353.
7. Changelian, P. S., and D. T. Fearon. 1986. Tissue-specific phosphorylation of complement receptors CR1 and CR2. J. Exp. Med. 163:101.
8. Thornton, B. P., V. Vetvicka, and G. D. Ross. 1994. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152:1727.
9. Illges, H., M. Braun, H. H. Peter, and I. Melchers. 1997. Analysis of the human CD21 transcription unit reveals differential splicing of exon II in mature transcripts and excludes alternative splicing as the mechanism causing solubilization of CD21. Mol. Immunol. 34:683.
10. Liu, Y-J., J. Xu, O. de Bouteiller, C. L. Parham, G. Grouard, O. Djossou, B. de Saint-Vis, S. Lebecque, J. Banchereau, and K. W. Moore. 1997. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J. Exp. Med. 185:165.
11. Young, L. S., C. W. Dawson, K. W. Brown, and A. B. Rickinson. 1989. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int. J. Cancer 43:786.
12. Hein, W. R., L. Dudler, and C. R. Mackay. 1989. Surface expression of differentiation antigens on lymphocytes in the ileal and jejunal Peyer's patches of lambs. Immunology 68:365.
13. Griebel, P. J. 1997. Isolation of lymphoid follicles from Peyer's patches. In Immunology Methods Manual. I. Lefkovits, ed. Academic Press, San Diego, CA, p. 2079.
14. Dudler, L., P. J. Griebel, and W. R. Hein. 1997. Separation of mononuclear cells from blood. In Immunology Methods Manual. I. Lefkovits, ed. Academic Press, San Diego, CA, p. 2075.
15. Young, A. J., W. R. Hein, and J. B. Hay. 1997. Cannulation of lymphatic vessels and its use in the study of lymphocyte traffic. In Immunology Methods Manual. I. Lefkovits, ed. Academic Press, San Diego, CA, p. 2037.
16. Young, A. J., W. L. Marston, M. Dessing, L. Dudler, and W. R. Hein. 1997. Distinct recirculating and non-recirculating B-lymphocyte pools in the peripheral blood are defined by coordinated expression of CD21 and L-selectin. Blood 90: 4865.
17. Tamura, G. S., M. O. Dailey, W. M. Gallatin, M. S. McGrath, I. L. Weissman, and E. A. Pillemer. 1984. Isolation of molecules recognized by monoclonal antibodies and antisera: the solid phase immunoisolation technique. Anal. Biochem. 136:458.
18. Laemmli, U. K. 1974. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
19. Matsudaira, P. 1987. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262:10035.
20. Haas, A. L., and P. M. Bright. 1985. The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates. J. Biol. Chem. 260:12464.
21. Tam, J. P. 1988. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA 85: 5409.
22. Cleveland, D. W., S. G. Fischer, M. W. Kirschner, and U. K. Laemmli. 1977. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J. Biol. Chem. 252:1102.
23. Wempe, F., and K. H. Scheit. 1993. Characterization of a full-length cDNA clone encoding a bovine four tandem-repeat of ubiquitin. Biochim. Biophys. Acta 1172: 209.
24. Lambris, J. D., N. J. Dobson, and G. D. Ross. 1980. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for β1H globulin. J. Exp. Med. 152:1625.
25. Moore, M. D., N. R. Cooper, B. F. Tack, and G. R. Nemerow. 1987. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc: Natl. Acad. Sci. USA 84:9194.
26. Fingeroth, J. D., M. A. Benedict, D. N. Levy, and J. L. Strominger. 1989. Identification of murine complement receptor type 2. Proc. Natl. Acad. Sci. USA 86:242.
27. Molina, H., T. Kinoshita, K. Inque, J-C. Carel, and V. M. Holers. 1990. A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145:2974.
28. Fujisaku, A., J. B. Harley, M. B. Frank, B. A. Gruner, B. Frazier, and V. M. Holers. 1989. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J. Biol. Chem. 264:2118.
29. de Bruyn, M. H. L., and G. H. Fey. 1985. Human complement component C3: cDNA coding sequence and derived primary structure. Proc. Natl Acad. Sci. USA 82:708.
30. Wetsel, R. A., A. Lundwall, F. Davidson, T. Gibson, B. F. Tack, and G. H. Fey. 1984. Structure of murine complement component C3. II. Nucleotide sequence of cloned complementary DNA coding for the a chain. J. Biol. Chem. 259:13857.
31. Lambris, J. D., V. S. Ganu, S. Hirani, and H. J. Müller-Eberhard. 1985. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc. Natl. Acad. Sci. USA 82:4235.
32. Hochstrasser, M. 1996. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30:405.
33. Hochstrasser, M. 1996. Protein degradation or regulation: Ub the judge. Cell 84:813.
34. Hicke, L. 1997. Ubiquitin-dependent internalization and down-regulation of plasma membrane proteins. FASEB J. 11:1215.
35. Lemmon, M. A., H. R. Treutlein, P. D. Adams, A. T. Brünger, and D. M. Engelman. 1994. A dimerization motif for transmembrane α-helices. Nat. Struct. Biol. 1:157.
36. MacKenzie, K. R., J. H. Prestegard, and D. M. Engelman. 1997. A transmembrane helix dimer: structure and implications. Science 276:131.
37. Delcayre, A. X., A. Fiandino, M. Barel, and R. Frade. 1987. gp140, the EBV/C3d receptor (CR2) of human B lymphocytes, is involved in cell-free phosphorylation of p120, a nuclear ribonucleoprotein. Eur. J. Immunol. 17:1827.
38. Pearson, R. B., and B. E. Kemp. 1991. Protein kinase phosphorylation site sequences and consensus specificity motifs. Methods Enzymol. 200:62.
39. Hunter, T., and J. A. Cooper. 1985. Protein-tyrosine kinases. Annu. Rev. Biochem. 54:897.
40. Songyang, Z., K. L. Carraway, M. J. Eck, S. C. Harrison, R. A. Feldman, M. Mohammadi, J. Schlessinger, S. R. Hubbard, D. P. Smith, C. Eng, M. J. Lorenzo, B. A. J. Ponder, B. J. Mayer, and L. C. Cantley. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536.
41. Lowell, C. A., L. B. Klickstein, R. H. Carter, J. A. Mitchell, D. T. Fearon, and J. M. Ahearn. 1989. Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2. J. Exp. Med. 170:1931.
42. Tedder, T. F., M. Inaoki, and S. Sato. 1997. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6:107.
43. Delcayre, A. X., F. Salas, S. Mathur, K. Kovats, M. Lotz, and W. Lernhardt. 1991. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor. EMBO J. 10:919.
44. Aubry, J. P., S. Pochon, P. Graber, K. U. Jansen, and J. Y. Bonnefoy. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505.
45. Tuveson, D. A., J. M. Ahearn, A. K. Matsumoto, and D. T. Fearon. 1991. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex. J. Exp. Med. 173:1083.
46. Molina, H., W. Wong, T. Kinoshita, C. Brenner, S. Foley, and V. M. Holers. 1992. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the genetic homologues of human CR1. J. Exp. Med. 175:121.
47. Naessens, J., and C. J. Howard. 1991. Monoclonal antibodies reacting with bovine B cells (BoWC3, BoWC4 and BoWC5). Vet. Immunol. Immunopathol. 22:77.